Abstract
Given the current massive global presence of fungal infections, their extensive risk group, widespread diagnostic limitations, and high mortality rate, there is an urgent need to develop new drugs to fight this critical global health scenario. Knowing that numerous drugs have emerged based on the observation of secondary metabolites isolated from natural products, we understand that attin…